CrossrefInfokarte
Immune checkpoint inhibitors combined with chemotherapy enhance coagulation activation and elevate venous thromboembolism risk in non-small cell lung cancer
American Journal of Cancer Research · 2026 · 16 (1) · 338-352
DOI: 10.62347/fygp7808 ↗Abstract
Kein Abstract verfügbar.
EUVIMED